Lillian M. Smyth

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 956 citations · Full text

Breast Oncology, Genomic Landscape, Cancer Genomics +3

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations

David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue et al. · Journal of Clinical Oncology · 2017 · 315 citations · Full text

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

A. Rose Brannon, Gowtham Jayakumaran, Monica Diosdado et al. · Nature Communications · 2021 · 172 citations · Full text

Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and <i><scp>TERT</scp></i> promoter hotspot mutations and <i>TERT</i> gene amplification as likely drivers of progression

Salvatore Piscuoglio, Charlotte K.Y. Ng, Melissa P. Murray et al. · The Journal of Pathology · 2015 · 127 citations · Full text

Breast Oncology, Engineering, Cancer Pathology +19